gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · BNGOHealthcareLab Analytical Instruments

Bionano Genomics, Inc. Common Stock (BNGO)

$1.19−0.83%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$1.20▼ 30.52% in range
Nov 3, 2025Low $1.06 · High $1.85Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Bionano Genomics closed at $1.19 on Nov 4, down 0.83%, 35.7% below its 52-week closing high. Volume of 72.3K shares was 0.39× its 20-day average (below normal).

Split-adjusted performance: -17.9% over one month, -6.3% over six months, -30.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $8.17M, up 21.4% from a year earlier, with a net margin of -90.8%.

Short interest was 1.4M shares at the Oct 15 settlement, down 33.2% from the prior report (12.8% of float, 5.7 days to cover).

Market cap$16.6M14.0M shares
Revenue · quarter$8.2M+21.4% YoY
Diluted EPS$-0.64—
P/E · TTM—P/S 0.6×
Net margin-90.8%Gross 52.8%
Dividend yieldNone
52-week range1.06 – 1.85−35.7% from high
Volume72.3K0.39× 20-day avg
Volatility · 60d69.6%Annualised
Short % of float12.8%5.7 days to cover
Net cash$6.2MCash $9.9M
Next earnings—Not scheduled
Split-adjusted performance
1W −1.2%1M −17.9%3M +8.2%6M −6.3%YTD −22.2%1Y −30.8%3Y −98.5%5Y −100.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Lab Analytical Instruments

Percentile among 22 companies (100 = best)

6-month momentum30
Revenue growth79
Net margin33
Value (low P/E)—
Size5

Industry medians: 6-month return +33.8%, revenue growth +4.9%, net margin −19.0%, P/E 38.3×.

Short interest

Details →
Shares short1.4M−33.2% vs prior
Days to cover5.7Settled Oct 15
% of float12.8%
Short vol. 10d55.9%of daily volume

Closest peers by size in Lab Analytical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
BNGOBionano Genomics$1.19−0.83%−6.3%+21.4%−90.8%—$16.6M
ASTCAstrotech Corporation (DE)$4.51−7.20%+62.2%−42.7%−2592.1%—$9.5MCompare
EYPTEyePoint$0.3950−1.23%−97.0%−90.5%−18633.1%—$34.1MCompare
RPIDRapid Micro Biosystems$0.6814−1.53%−73.1%+10.9%−160.5%—$34.2MCompare
PRPOPrecipio$19.57+5.10%−34.7%+24.7%−3.1%—$35.0MCompare
HBIOHarvard Bioscience$8.61−0.69%+18.9%+11.1%−12.8%—$39.2MCompare
SEERSeer$1.70−1.73%−10.1%−23.4%−544.8%—$94.1MCompare
QTRXQuanterix$3.04+3.40%−7.6%+34.4%−148.7%—$143.8MCompare
NAUTNautilus Biotechnolgy$2.29−2.55%−22.1%—−6682.1%—$291.7MCompare

News about Bionano Genomics

All news →

No recent articles focused on Bionano Genomics.

Quick answers

What does Bionano Genomics do?
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
What is BNGO's market cap?
$16.63M, based on the Nov 4 close of $1.19.
Does Bionano Genomics pay a dividend?
No regular cash dividend has been paid in the last year.
How much of BNGO is sold short?
1.4M shares, 12.8% of float, as of Oct 15, 2026.
What sector is BNGO in?
Healthcare, in the Lab Analytical Instruments industry.

About Bionano Genomics

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

HQ: San Diego, CA97 employeesListed Aug 1, 2018bionano.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology